Information Journal Paper
APA:
Copy. (2018). Use of rituximab as an induction therapy in anti-glomerular basement-membrane disease. BMC NEPHROLOGY, 19(1), 0-0. SID. https://sid.ir/paper/750106/en
Vancouver:
Copy. Use of rituximab as an induction therapy in anti-glomerular basement-membrane disease. BMC NEPHROLOGY[Internet]. 2018;19(1):0-0. Available from: https://sid.ir/paper/750106/en
IEEE:
Copy, “Use of rituximab as an induction therapy in anti-glomerular basement-membrane disease,” BMC NEPHROLOGY, vol. 19, no. 1, pp. 0–0, 2018, [Online]. Available: https://sid.ir/paper/750106/en